Literature DB >> 26893861

Occurrence of an intrathoracic desmoid tumor following breast cancer treatment: A case report.

Serkan Değirmencioğlu1, Gokcen Demiray1, Arzu Yaren1, Ferda Bir2, Duygu Herek3.   

Abstract

Desmoid tumors are rarely observed tumors that develop from deep muscle and aponeurotic tissues. They are histologically intermediate, and exhibit a local aggressive course. These tumors have been observed in the abdominal region, and are rarely encountered in the thoracic wall. The most effective treatment appears to be surgery. A 59-year-old female patient was admitted with the complaint of right breast pain and a palpable mass. The patient had undergone a modified radical mastectomy surgical procedure of the right breast due to invasive breast carcinoma 10 years before. A mass with a soft tissue density and a size of 44×22 mm was detected in the thoracic computed tomography of the patient, which subsequently resulted in biopsy followed by surgery. As a result of the pathological examination of the mass, the diagnosis was determined as desmoid tumor. Due to the closeness of the tumor to the surgical margin, the patient was administered radiotherapy and maintenance imatinib treatment was started.

Entities:  

Keywords:  breast cancer; desmoid tumor; thoracic wall

Year:  2015        PMID: 26893861      PMCID: PMC4734083          DOI: 10.3892/mco.2015.698

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  12 in total

1.  Extended resection of a chest wall desmoid tumour with concomitant coronary artery bypass grafting.

Authors:  M Kostolny; H Präuer; N Augustin; R Lange
Journal:  Eur J Cardiothorac Surg       Date:  2001-11       Impact factor: 4.191

2.  Unusual problems in breast cancer and a rare lung cancer case. Case 2. Aggressive fibromatosis of the chest wall arising near a breast prosthesis.

Authors:  Kaouthar Khanfir; Jean-Marc Guinebretiere; Daniel Vanel; Lise Barreau-Pouhaer; Sylvie Bonvalot; Axel Le Cesne
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

3.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.

Authors:  M T Ballo; G K Zagars; A Pollack; P W Pisters; R A Pollack
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

4.  Desmoid tumors of the chest wall.

Authors:  P J Allen; C D Shriver
Journal:  Semin Thorac Cardiovasc Surg       Date:  1999-07

5.  Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Yoji Shido; Junji Wasa; Naoki Ishiguro; Yoshihisa Yamada
Journal:  J Clin Oncol       Date:  2009-12-21       Impact factor: 44.544

6.  Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.

Authors:  N Penel; A Le Cesne; B N Bui; D Perol; E G Brain; I Ray-Coquard; C Guillemet; C Chevreau; D Cupissol; S Chabaud; M Jimenez; F Duffaud; S Piperno-Neumann; L Mignot; J-Y Blay
Journal:  Ann Oncol       Date:  2010-07-09       Impact factor: 32.976

7.  Desmoid tumors of the chest wall.

Authors:  E H Kabiri; S Al Aziz; A El Maslout; A Benosman
Journal:  Eur J Cardiothorac Surg       Date:  2001-05       Impact factor: 4.191

8.  Desmoid tumors (fibromatoses) of the breast: a 25-year experience.

Authors:  Heather B Neuman; Edi Brogi; Amber Ebrahim; Murray F Brennan; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

Review 9.  The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification.

Authors:  Christopher D M Fletcher
Journal:  Histopathology       Date:  2013-10-25       Impact factor: 5.087

10.  Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis.

Authors:  K Tsukada; J M Church; D G Jagelman; V W Fazio; E McGannon; C R George; T Schroeder; I Lavery; J Oakley
Journal:  Dis Colon Rectum       Date:  1992-01       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.